• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨磺必利撤药后运动障碍:一例报告

Amisulpride withdrawal dyskinesia: a case report.

作者信息

Lo Yu-Chi, Peng Ying-Chieh

机构信息

Ministry of Health and Welfare Kinmen Hospital, No. 2, Fuxing Rd., Jinhu Township, Kinmen County, 89142 Taiwan.

Bali Psychiatric Center, No. 33, Huafushan, Bali Dist., New Taipei City, 24936 Taiwan.

出版信息

Ann Gen Psychiatry. 2017 Jun 14;16:25. doi: 10.1186/s12991-017-0148-0. eCollection 2017.

DOI:10.1186/s12991-017-0148-0
PMID:28630641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5471910/
Abstract

BACKGROUND

The effects of antipsychotic drug withdrawal have been inadequately studied. Case reports have described dyskinesia occurring in patients with several antipsychotics withdrawn, but studies on amisulpride withdrawal dyskinesia are lacking.

CASE PRESENTATION

A 63-year-old man, who was diagnosed with schizophrenia at age 49, received amisulpride treatment since age 62. The dosage of amisulpride was reduced from 200 to 50 mg/day because of occurrence of akathisia during one admission. Severe withdrawal dyskinesia, mixed with dystonia and akathisia, was noted immediately after the dosage reduction. The abnormal involuntary movement showed improvement 2 weeks later when the dosage was increased to 100 mg/day.

CONCLUSIONS

Withdrawal dyskinesia and other abnormal involuntary movements could be noted in a patient with reduction of amisulpride dosage or sudden termination. Withdrawal dyskinesia may subsequently lead to persistent tardive dyskinesia. Therefore, withdrawal-emergent dyskinesia should be promptly identified, and appropriate medical interventions should be given early.

摘要

背景

抗精神病药物撤药的影响尚未得到充分研究。病例报告描述了多种抗精神病药物撤药的患者出现运动障碍,但缺乏对阿立哌唑撤药后运动障碍的研究。

病例介绍

一名63岁男性,49岁时被诊断为精神分裂症,自62岁起接受阿立哌唑治疗。因一次住院期间出现静坐不能,阿立哌唑剂量从200毫克/天减至50毫克/天。剂量减少后立即出现严重的撤药运动障碍,伴有肌张力障碍和静坐不能。当剂量增加到100毫克/天时,异常的不自主运动在2周后有所改善。

结论

阿立哌唑剂量减少或突然停药的患者可能会出现撤药运动障碍和其他异常不自主运动。撤药运动障碍可能随后导致持续性迟发性运动障碍。因此,应及时识别撤药后出现的运动障碍,并尽早给予适当的医学干预。

相似文献

1
Amisulpride withdrawal dyskinesia: a case report.氨磺必利撤药后运动障碍:一例报告
Ann Gen Psychiatry. 2017 Jun 14;16:25. doi: 10.1186/s12991-017-0148-0. eCollection 2017.
2
Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report.氨磺必利撤药性静坐不能经阿立哌唑联合普萘洛尔治疗首发精神分裂症 1 例报告
BMC Psychiatry. 2022 Jan 29;22(1):74. doi: 10.1186/s12888-022-03721-9.
3
Covert Dyskinesia With Aripiprazole: Tip of the Iceberg? A Case Report and Literature Review.阿立哌唑致隐匿性运动障碍:冰山一角?病例报告及文献复习。
J Clin Psychopharmacol. 2021;41(1):67-70. doi: 10.1097/JCP.0000000000001333.
4
Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.抗精神病药物撤药后静坐不能与抗精神病药物所致静坐不能:迟发性静坐不能存在的进一步证据
J Clin Psychiatry. 1988 Nov;49(11):435-8.
5
Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.新型抗精神病药物、锥体外系副作用与迟发性运动障碍
Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S49-57. doi: 10.1097/00004850-199803003-00009.
6
Amisulpride Reexposure and Tardive Dyskinesia.氨磺必利再暴露与迟发性运动障碍
Indian J Psychol Med. 2018 Jan-Feb;40(1):91-92. doi: 10.4103/IJPSYM.IJPSYM_140_17.
7
Switching to amisulpride.换用氨磺必利。
Curr Med Res Opin. 2002;18 Suppl 3:s23-8. doi: 10.1185/030079902125001092.
8
Managing antipsychotic-induced tardive dyskinesia.治疗抗精神病药物所致迟发性运动障碍。
Drug Saf. 1999 Feb;20(2):187-93. doi: 10.2165/00002018-199920020-00007.
9
Amisulpride-induced tardive dyskinesia.氨磺必利所致迟发性运动障碍。
Schizophr Res. 2006 Dec;88(1-3):232-4. doi: 10.1016/j.schres.2006.08.001. Epub 2006 Sep 11.
10
Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study.未使用过第一代抗精神病药物的非老年精神分裂症患者使用第二代抗精神病药物后的迟发性运动障碍和迟发性肌张力障碍:一项横断面回顾性研究。
J Clin Psychopharmacol. 2015 Feb;35(1):13-21. doi: 10.1097/JCP.0000000000000250.

引用本文的文献

1
Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report.氨磺必利撤药性静坐不能经阿立哌唑联合普萘洛尔治疗首发精神分裂症 1 例报告
BMC Psychiatry. 2022 Jan 29;22(1):74. doi: 10.1186/s12888-022-03721-9.
2
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.迟发性运动障碍的治疗:概述及重点关注囊泡单胺转运体 2 抑制剂。
Drugs. 2018 Apr;78(5):525-541. doi: 10.1007/s40265-018-0874-x.

本文引用的文献

1
Tardive dyskinesia occurring in a young woman after withdrawal of an atypical antipsychotic drug.一名年轻女性在停用非典型抗精神病药物后出现迟发性运动障碍。
Neurosciences (Riyadh). 2015 Oct;20(4):376-9. doi: 10.17712/nsj.2015.4.20150078.
2
Experiencing antipsychotic discontinuation: results from a survey of Australian consumers.经历抗精神病药物停药:一项针对澳大利亚消费者的调查结果
J Psychiatr Ment Health Nurs. 2014 Dec;21(10):917-23. doi: 10.1111/jpm.12178. Epub 2014 Oct 9.
3
An aripiprazole discontinuation syndrome.阿立哌唑撤药综合征。
R I Med J (2013). 2013 Feb;96(2):13-4.
4
Covert dyskinesia associated with aripiprazole: a case report and review of the literature.阿立哌唑相关的隐匿性运动障碍:一例报告及文献复习
Clin Neuropharmacol. 2013 Jul-Aug;36(4):128-30. doi: 10.1097/WNF.0b013e31829b99d9.
5
Zolpidem improves tardive dyskinesia and akathisia.唑吡坦可改善迟发性运动障碍和静坐不能。
Mov Disord. 2013 Oct;28(12):1748-9. doi: 10.1002/mds.25480. Epub 2013 May 1.
6
Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis.迟发性运动障碍是由适应性突触可塑性引起的:一种假说。
Mov Disord. 2012 Sep 1;27(10):1205-15. doi: 10.1002/mds.25107. Epub 2012 Aug 1.
7
Vitamin E for neuroleptic-induced tardive dyskinesia.维生素E治疗抗精神病药所致迟发性运动障碍
Cochrane Database Syst Rev. 2011 Feb 16(2):CD000209. doi: 10.1002/14651858.CD000209.pub2.
8
Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders.
J Clin Psychopharmacol. 2007 Dec;27(6):705-7. doi: 10.1097/JCP.0b013e31815a5870.
9
Evidence that lithium protects against tardive dyskinesia: the Curaçao Extrapyramidal syndromes study VI.
Eur Neuropsychopharmacol. 2008 Feb;18(2):152-5. doi: 10.1016/j.euroneuro.2007.07.004. Epub 2007 Sep 5.
10
Risperidone withdrawal-related respiratory dyskinesia: a case diagnosed by spirography and fibroscopy.
Clin Neuropharmacol. 2005 Mar-Apr;28(2):90-3. doi: 10.1097/01.wnf.0000161637.81752.b3.